PSA, PCA3 and the phi losophy of prostate cancer management

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F13%3A%230000615" target="_blank" >RIV/00098892:_____/13:#0000615 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

PSA, PCA3 and the phi losophy of prostate cancer management

Original language description

The fundamental role that laboratory medicine currently takes in the management of cancer patients is probably more visible in prostate cancer than any other tumor. In patients with prostate cancer, laboratory medicine plays not only a crucial role in the early diagnosis, but also has a major impact on subsequent phases of the management of the patient throughout the entire course of the disease. The advent of prostate specific antigen (PSA) testing has transformed the management of prostate cancer.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Clinical Chemistry and Laboratory Medicine

ISSN

1434-6621

e-ISSN

—

Volume of the periodical

51

Issue of the periodical within the volume

4

Country of publishing house

DE - GERMANY

Number of pages

6

Pages from-to

707-712

UT code for WoS article

—

EID of the result in the Scopus database

—